
|Articles|March 20, 2006
Newsbriefs
New software and hardware
Advertisement
New software and hardware
Highlighting hypertension
Fibrinolytics before surgery questioned
Rather than helping patients, clot-busters given to heart attack patients before an angioplasty is performed may actually increase the risk of subsequent myocardial infarctions and strokes. These are the conclusions of several studies published in the Feb. 18 issue of the Lancet. The findings are expected to provoke a review by the medical community of the practice of administering anticlotting drugs to facilitate an angioplasty.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Addressing Depression Symptoms Can Significantly Improve Asthma Outcomes
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
What the Newest Landmark PBM Reform Means for the Pharmacy Industry
4
TrumpRx Officially Launches, Introduces Drug Prices
5























